Grail Inc GRAL

US Biotechnology

$136.57 ▲ +2.97% (+$3.94)

🎯 52W High ⬆️ Above Yest. High 🔥 High Short Interest 🎢 High Beta

Open $132.75

Prev Close $132.63

Day Range $131.20 – $140.88

52W Range $41.50 – $134.42

Market Cap $6.10B

Beta 1.96

EPS (TTM) $-9.75

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2024-06-12
Shares Out.	42,920,000
Website	grail.com/ ↗
Phone	13026587581
Employees	910
Revenue	$44.7M
Gross Profit	-$12.6M
Net Income	-$110.2M
Free Cash Flow	-$296.2M
Total Assets	$2.84B
Total Liabilities	$301.0M
Equity	$2.54B

About Grail Inc

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Grail Inc is a publicly traded company under the ticker symbol GRAL on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.